1. Home
  2. Labeler Index
  3. Galt Pharmaceuticals, Llc
  4. 61825-302
  5. NDC Package Code: 61825-302-60 Orphengesic Forte

NDC Package 61825-302-60 Orphengesic Forte

Orphenadrine Citrate,Aspirin And Caffeine Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61825-302-60
Package Description:
60 TABLET in 1 BOTTLE, PLASTIC
Product Code:
61825-302
Proprietary Name:
Orphengesic Forte
Non-Proprietary Name:
Orphenadrine Citrate, Aspirin And Caffeine
Substance Name:
Aspirin; Caffeine; Orphenadrine Citrate
Usage Information:
Orphengesic Forte (Orphenadrine Citrate, Aspirin and Caffeine 50 mg/ 770 mg/ 60 mg) Tablets are indicated in:Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. Orphengesic Forte Tablets do not directly relax tense muscles in man.
11-Digit NDC Billing Format:
61825030260
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
60 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 994535 - orphenadrine citrate 50 MG / aspirin 770 MG / caffeine 60 MG Oral Tablet
  • RxCUI: 994535 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • RxCUI: 994535 - ASA 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • RxCUI: 994539 - ORPHENGESIC FORTE 50 MG / 770 MG / 60 MG Oral Tablet
  • RxCUI: 994539 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet [Orphengesic]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Galt Pharmaceuticals, Llc
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ASPIRIN 770 mg/1
  • CAFFEINE 60 mg/1
  • ORPHENADRINE CITRATE 50 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
  • Centrally-mediated Muscle Relaxation - [PE] (Physiologic Effect)
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Platelet Aggregation - [PE] (Physiologic Effect)
  • Decreased Prostaglandin Production - [PE] (Physiologic Effect)
  • Methylxanthine - [EPC] (Established Pharmacologic Class)
  • Muscle Relaxant - [EPC] (Established Pharmacologic Class)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
  • Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
  • Xanthines - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA075141
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-08-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61825-302-60?

    The NDC Packaged Code 61825-302-60 is assigned to a package of 60 tablet in 1 bottle, plastic of Orphengesic Forte, a human prescription drug labeled by Galt Pharmaceuticals, Llc. The product's dosage form is tablet and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package.

    Is NDC 61825-302 included in the NDC Directory?

    Yes, Orphengesic Forte with product code 61825-302 is active and included in the NDC Directory. The product was first marketed by Galt Pharmaceuticals, Llc on June 08, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 61825-302-60?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 61825-302-60?

    The 11-digit format is 61825030260. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-261825-302-605-4-261825-0302-60